Fiorino, G.; Ananthakrishnan, A.; Cohen, R.D.; Cross, R.K.; Deepak, P.; Farraye, F.A.; Halfvarson, J.; Steinhart, A.H.
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. J. Clin. Med. 2025, 14, 1561.
https://doi.org/10.3390/jcm14051561
AMA Style
Fiorino G, Ananthakrishnan A, Cohen RD, Cross RK, Deepak P, Farraye FA, Halfvarson J, Steinhart AH.
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. Journal of Clinical Medicine. 2025; 14(5):1561.
https://doi.org/10.3390/jcm14051561
Chicago/Turabian Style
Fiorino, Gionata, Ashwin Ananthakrishnan, Russell D. Cohen, Raymond K. Cross, Parakkal Deepak, Francis A. Farraye, Jonas Halfvarson, and A. Hillary Steinhart.
2025. "Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease" Journal of Clinical Medicine 14, no. 5: 1561.
https://doi.org/10.3390/jcm14051561
APA Style
Fiorino, G., Ananthakrishnan, A., Cohen, R. D., Cross, R. K., Deepak, P., Farraye, F. A., Halfvarson, J., & Steinhart, A. H.
(2025). Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. Journal of Clinical Medicine, 14(5), 1561.
https://doi.org/10.3390/jcm14051561
